CFD'er er komplekse instrumenter, og der er stor risiko for at miste penge hurtigt på grund af gearing. 84% af individuelle investorer taber penge, når de handler CFD'er med denne udbyder. Du bør overveje, om du forstår, hvordan CFD'er virker, og om du har råd til at løbe en høj risiko for at miste dine penge.
Capital Com Australia Pty Ltd Reguleret af ASIC Capital Com UK Limited Reguleret af Financial Conduct Authority (FCA) Capital Com SV Investments Limited Reguleret af CYSEC Сlosed Joint Stock Company «FinTech Solutions» Reguleret af NBRB Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Reguleret af FSA Capital Com Online Investments Ltd Reguleret af SCB Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Du kan også kontakte os: ring +44 2030978888 support@capital.com

Handel Evotec AG - EVT CFD

17.660
2.19%
0.085
Lav: 17.575
Høj: 17.98
Market Trading Hours* (UTC) Opens on Thursday at 08:00

Mon - Fri: 08:00 - 16:30

  • Opsummering
  • Historisk Data
  • Begivenheder
  • Resultatopgørelse
  • Saldo
  • Cash flow
  • Ejerskab
Handelsbetingelser
Spænd 0.085
Long position, gebyr natten over

Long position overnight fee

Margin. Your investment $1,000.00
Gebyr for natten over -0.017913 %
Charges from borrowed part ($-0.72)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Gå til platform
-0.017913%
Short position, gebyr natten over

Short position overnight fee

Margin. Your investment $1,000.00
Gebyr for natten over -0.004309 %
Charges from borrowed part ($-0.17)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Gå til platform
-0.004309%
Gebyr natten over, tid 21:00 (UTC)
Min. handlet mængde 1
Valuta EUR
Margen 20%
Aktiebørs Germany
Kommission på handel 0%

*Information provided by Capital.com

Evotec SE ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

Nøglestatistikker
Tidligere luk* 18.055
Åben* 17.98
1-Års Ændring* -35.73%
Dagens Spænd* 17.575 - 17.98
52-Ugers Spænd 14.80-29.71
Gennemsnitlig Volumen (10 dage) 521.93K
Gennemsnitlig Volumen (3 måneder) 8.76M
Market Cap 3.21B
P/E-forhold -100.00K
Udestående aktier 176.94M
Omsætning 697.83M
EPS -1.02
Dividend (Udbytte %) N/A
Beta 0.82
Næste indtjeningsopgørelse Mar 28, 2023

Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Luk Change Change (%) Åben High Low
Mar 21, 2023 18.055 0.085 0.47% 17.970 18.315 17.910
Mar 20, 2023 17.850 -0.110 -0.61% 17.960 18.065 17.540
Mar 17, 2023 18.075 -0.325 -1.77% 18.400 18.690 17.835
Mar 16, 2023 18.265 0.700 3.99% 17.565 18.295 17.375
Mar 15, 2023 17.125 -0.495 -2.81% 17.620 17.670 16.780
Mar 14, 2023 17.640 0.375 2.17% 17.265 17.890 17.265
Mar 13, 2023 17.280 0.125 0.73% 17.155 17.400 16.825
Mar 10, 2023 17.130 0.390 2.33% 16.740 17.330 16.675
Mar 9, 2023 17.255 -0.185 -1.06% 17.440 17.445 17.110
Mar 8, 2023 17.535 -0.085 -0.48% 17.620 17.800 17.315
Mar 7, 2023 17.745 -0.175 -0.98% 17.920 18.220 17.575
Mar 6, 2023 17.540 0.085 0.49% 17.455 17.575 17.150
Mar 3, 2023 17.190 0.300 1.78% 16.890 17.220 16.760
Mar 2, 2023 16.615 0.205 1.25% 16.410 16.770 16.410
Mar 1, 2023 16.590 -0.515 -3.01% 17.105 17.130 16.525
Feb 28, 2023 16.975 -0.650 -3.69% 17.625 17.625 16.905
Feb 27, 2023 17.820 0.115 0.65% 17.705 17.895 17.620
Feb 24, 2023 17.420 -0.790 -4.34% 18.210 18.310 17.420
Feb 23, 2023 18.310 -0.115 -0.62% 18.425 18.550 18.235
Feb 22, 2023 18.285 -0.005 -0.03% 18.290 18.315 17.950

Evotec AG Events

Tid (UTC) (UTC) Land Begivenhed
No events scheduled
Se alle begivenheder
  • Årlig
  • Pr kvartal
2021 2020 2019 2018 2017
Total omsætning 618.034 500.924 446.437 375.405 263.765
Omsætning 618.034 500.924 446.437 375.405 263.765
Kost af omsætning, Total 466.491 375.181 313.546 263.389 181.965
Bruttofortjeneste 151.543 125.743 132.891 112.016 81.8
Totale Driftsudgifter 588.901 452.368 383.843 297.942 227.038
Salgs/Generelle/Admin. Udgifter, Total 105.445 77.205 66.546 57.012 42.383
Forskning & Udvikling 72.2 63.945 58.432 35.619 17.614
Usædvanlig Udgift (Indkomst) 12.546 3.244 11.919 -11.036 1.18
Other Operating Expenses, Total -67.781 -67.207 -66.6 -47.042 -16.104
Driftsindtægter 29.133 48.556 62.594 77.463 36.727
Renteindkomst (Udgift), Netto Ikke-Drift 208.106 -22.925 -6.102 -5.602 -10.37
Andre, Netto -0.259 0.209 0.07 0.138 -0.792
Netto Indkomst Før Skat 236.98 25.84 56.562 71.999 25.565
Netto Indkomst Efter Skat 215.51 6.278 37.228 84.056 23.218
Minoritetsrente 0 0 0.844 0.116 0.258
Netto Indkomst Før Ekstra Ting 215.51 6.278 38.072 84.172 23.476
Netto Indkomst 215.51 6.278 38.072 84.172 23.476
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting 215.51 6.278 38.072 84.172 23.476
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting 215.51 6.278 38.072 84.172 23.476
Fortyndet Netto Indkomst 215.51 6.278 38.072 84.172 23.476
Fortyndet Vægtet Gennemsnit Aktier 166.406 153.752 149.726 147.482 145.01
Fortyndet EPS Uden Ekstraordinære Ting 1.29509 0.04083 0.25428 0.57073 0.16189
Dividends per Share - Common Stock Primary Issue 0 0 0 0 0
Fortyndet Normaliseret EPS 1.36365 0.05455 0.30667 0.52209 0.16928
Fortyndelsesændring 0
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total omsætning 164.672 187.071 159.661 138.217 133.085
Omsætning 164.672 187.071 159.661 138.217 133.085
Kost af omsætning, Total 132.378 134.997 116.494 112.594 102.406
Bruttofortjeneste 32.294 52.074 43.167 25.623 30.679
Totale Driftsudgifter 164.209 179.5 146.414 136.68 126.307
Salgs/Generelle/Admin. Udgifter, Total 31.566 34.408 24.654 25.189 21.194
Forskning & Udvikling 18.113 18.728 18.038 16.974 18.46
Other Operating Expenses, Total -17.848 -16.005 -17.263 -18.76 -15.753
Driftsindtægter 0.463 7.571 13.247 1.537 6.778
Renteindkomst (Udgift), Netto Ikke-Drift -69.555 -25.191 127.127 58.478 47.692
Andre, Netto 0.359 -0.216 0.017 -0.03 -0.03
Netto Indkomst Før Skat -68.733 -17.836 140.391 59.985 54.44
Netto Indkomst Efter Skat -73.242 -31.478 134.271 60.015 52.702
Netto Indkomst Før Ekstra Ting -73.242 -31.478 134.271 60.015 52.702
Netto Indkomst -73.242 -31.478 134.271 60.015 52.702
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -73.242 -31.478 134.271 60.015 52.702
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -73.242 -31.478 134.271 60.015 52.702
Fortyndet Netto Indkomst -73.242 -31.478 134.271 60.015 52.702
Fortyndet Vægtet Gennemsnit Aktier 176.703 172.677 164.525 164.33 164.088
Fortyndet EPS Uden Ekstraordinære Ting -0.41449 -0.18229 0.81611 0.36521 0.32118
Dividends per Share - Common Stock Primary Issue 0 0 0 0 0
Fortyndet Normaliseret EPS -0.41449 -0.15454 0.84222 0.36791 0.32118
Usædvanlig Udgift (Indkomst) 7.372 4.491 0.683
Minoritetsrente 0
  • Årlig
  • Pr kvartal
2021 2020 2019 2018 2017
Totale Nuværende Aktiver 1100.94 658.844 469.53 249.769 177.783
Likvider og Kortsigtede Investeringer 858.498 492.634 321.662 149.879 91.947
Likvider & Lignende 699.326 422.58 277.034 109.055 67.017
Kortsigtede Investeringer 159.172 70.054 44.628 40.824 24.93
Totale Tilgodehavender, Netto 176.754 122.221 117.844 74.772 63.624
Accounts Receivable - Trade, Net 150.692 91.612 93.702 58.851 56.198
Total Inventory 25.793 13.585 10.749 5.66 5.568
Prepaid Expenses 19.21 9.258 9.166 8.451 8.6
Other Current Assets, Total 20.685 21.146 10.109 11.007 8.044
Total Assets 2235.16 1462.34 1180.91 771.883 666.475
Property/Plant/Equipment, Total - Net 484.597 337.297 239.229 90.519 76.069
Property/Plant/Equipment, Total - Gross 686.086 481.879 350.415 164.143 131.682
Accumulated Depreciation, Total -201.489 -144.582 -111.186 -73.624 -55.613
Goodwill, Net 257.569 247.37 255.919 220.791 220.447
Intangibles, Net 30.851 98.036 116.994 122.989 135.033
Long Term Investments 287.009 59.021 41.252 28.99 22.141
Note Receivable - Long Term 55.966 36.485 22.718 14.601 11.168
Other Long Term Assets, Total 18.229 25.284 35.27 44.224 23.834
Total Current Liabilities 324.516 208.459 178.955 196.275 242.945
Accounts Payable 72.598 42.549 31.319 31.137 26.078
Accrued Expenses 33.983 34.728 29.174 25.67 18.351
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 50.609 30.008 20.731 56.919 168.468
Other Current Liabilities, Total 167.326 101.174 97.731 82.549 30.048
Total Liabilities 857.476 737.881 703.883 347.879 335.552
Total Long Term Debt 462.308 461.957 442.368 57.546 21.46
Long Term Debt 326.344 331.019 324.886 54.68 20.295
Capital Lease Obligations 135.964 130.938 117.482 2.866 1.165
Deferred Income Tax 17.688 20.399 21.199 21.517 23.692
Minority Interest 0 0 0 0.876 0.992
Other Liabilities, Total 52.964 47.066 61.361 71.665 46.463
Total Equity 1377.69 724.456 477.029 424.004 330.923
Common Stock 176.608 163.915 150.903 149.063 147.533
Additional Paid-In Capital 1430.14 1030.7 786.865 783.154 778.858
Retained Earnings (Accumulated Deficit) -216.421 -432.639 -441.177 -481.013 -566.565
Unrealized Gain (Loss) 3.053 4.26 4.565 6.002 6.384
Other Equity, Total -15.691 -41.782 -24.127 -33.202 -35.287
Total Liabilities & Shareholders’ Equity 2235.16 1462.34 1180.91 771.883 666.475
Total Common Shares Outstanding 176.358 163.665 150.653 148.813 147.283
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Totale Nuværende Aktiver 1061.51 1100.94 628.306 634.802 680.401
Likvider og Kortsigtede Investeringer 855.045 858.498 427.228 459.703 470.576
Likvider & Lignende 660.488 699.326 333.404 382.311 401.597
Kortsigtede Investeringer 194.557 159.172 93.824 77.392 68.979
Totale Tilgodehavender, Netto 134.019 176.754 136.615 116.179 154.67
Accounts Receivable - Trade, Net 112.617 150.692 111.501 94.166 136.494
Total Inventory 26.076 25.793 22.519 17.254 15.237
Prepaid Expenses 46.373 39.895 41.944 41.666 39.918
Total Assets 2185.02 2235.16 1767.85 1621.12 1580.71
Property/Plant/Equipment, Total - Net 521.357 484.597 472.825 449.474 374.93
Goodwill, Net 257.649 257.569 253.709 252.961 254.041
Intangibles, Net 29.157 30.851 33.227 35.814 95.693
Long Term Investments 236.624 287.009 303.841 175.425 108.274
Note Receivable - Long Term 61.595 55.966 50.376 45.371 40.836
Other Long Term Assets, Total 17.128 18.229 25.565 27.269 26.532
Total Current Liabilities 339.62 324.516 253.778 246.947 239.606
Accounts Payable 74.739 72.598 56.72 51.363 54.88
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 50.641 50.609 49.356 63.909 30.145
Other Current Liabilities, Total 214.24 201.309 147.702 131.675 154.581
Total Liabilities 875.162 857.476 775.17 768.542 787.661
Total Long Term Debt 467.926 462.308 451.255 448.949 486.933
Long Term Debt 326.116 326.344 317.922 318.151 353.201
Capital Lease Obligations 141.81 135.964 133.333 130.798 133.732
Deferred Income Tax 17.552 17.688 19.208 19.58 20.654
Other Liabilities, Total 50.064 52.964 50.929 53.066 40.468
Total Equity 1309.86 1377.69 992.679 852.574 793.046
Common Stock 176.953 176.608 165.111 164.608 164.561
Additional Paid-In Capital 1432.45 1430.14 1035.44 1033.67 1032.13
Retained Earnings (Accumulated Deficit) -289.629 -216.421 -186.245 -320.691 -381.249
Other Equity, Total -9.912 -15.691 -21.625 -29.333 -22.395
Total Liabilities & Shareholders’ Equity 2185.02 2235.16 1767.85 1621.12 1580.71
Total Common Shares Outstanding 176.703 176.358 164.861 164.358 164.311
Unrealized Gain (Loss) 3.053 4.32
Minority Interest 0
  • Årlig
  • Pr kvartal
2021 2020 2019 2018 2017
Netto indkomst/Startlinje 215.51 6.252 37.228 84.056 23.218
Likvider Fra Driftsaktiviteter 122.237 44.721 42.216 156.24 10.828
Likvider Fra Driftsaktiviteter 55.596 42.122 36.456 19.288 13.725
Amortization 12.012 13.936 12.349 12.005 7.041
Deferred Taxes 5.066 7.49 6.706 -26.117 -6.131
Ikke-Likvide Ting -165.371 23.865 24.342 0.364 7.904
Cash Taxes Paid -6.028 9.796 2.417 3.596 0.103
Likvid Rente Betalt 5.429 3.465 4.49 2.279 0.822
Ændringer i Driftskapital -0.576 -48.944 -74.865 66.644 -34.929
Likvider fra Investeringsaktiviteter -243.855 -155.089 -86.634 -39.13 -269.033
Kapitaludgifter -118.943 -99.072 -31.905 -27.867 -17.587
Andre Investerings-Cash-Flow-Ting, Total -124.912 -56.017 -54.729 -11.263 -251.446
Likvider fra Financieringsaktiviteter 398.43 246.409 211.263 -77.764 240.724
Financiering af Cash-Flow-Ting
Udstedelse (Pensionering) af Aktier, Netto 404.322 251.564 1.901 1.578 92.356
Udstedelse (Pensionering) af Gæld, Netto -5.892 -5.155 209.362 -79.342 148.368
Udenlandsk Børs Effekter -0.066 9.505 1.134 2.692 0.558
Netto Ændring i Likviditet 276.746 145.546 167.979 42.038 -16.923
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -73.242 215.51 246.988 112.717 52.702
Cash From Operating Activities 63.618 122.237 61.902 41.105 2.459
Changes in Working Capital 136.86 -93.273 -185.086 -71.612 -50.243
Cash From Investing Activities -95.732 -243.855 -146.74 -96.457 -46.504
Capital Expenditures -42.921 -118.943 -100.183 -72.573 -36.297
Other Investing Cash Flow Items, Total -52.811 -124.912 -46.557 -23.884 -10.207
Cash From Financing Activities -5.279 398.43 -7.148 12.457 17.931
Issuance (Retirement) of Stock, Net 0.345 404.322 1.196 0.693 0.646
Issuance (Retirement) of Debt, Net -5.624 -5.892 -8.344 11.764 17.285
Foreign Exchange Effects -1.445 -0.066 2.81 2.626 5.131
Net Change in Cash -38.838 276.746 -89.176 -40.269 -20.983
Investornavn Investortype Procent udestående Aktiebeholdning Aktieændring Beholdningsdato IOmsætningsscore
T. Rowe Price International Ltd Investment Advisor/Hedge Fund 10.0958 17888267 197835 2022-11-10 MED
Novo Holdings A/S Venture Capital 9.8455 17444807 -206374 2022-12-31 LOW
Mubadala Investment Company PJSC Sovereign Wealth Fund 6.4799 11481502 2298850 2021-11-08 LOW
Government of Abu Dhabi Government Agency 6.4788 11479533 1602555 2021-12-31 LOW
T. Rowe Price Associates, Inc. Investment Advisor 5.0138 8883666 -1796 2023-01-31 LOW
BlackRock Asset Management Deutschland AG Investment Advisor 3.671 6504551 -2755 2022-06-03 LOW
Allianz Global Investors GmbH Investment Advisor 2.9667 5256528 -2846371 2022-01-07 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.5091 4445816 7452 2023-02-28 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 2.2224 3937850 851779 2022-12-31 LOW
Liontrust Investment Partners LLP Investment Advisor 2.1651 3836320 -8983 2023-01-31 LOW
Brown Capital Management, LLC Investment Advisor 2.165 3836114 -24213 2022-09-30 LOW
Oetker (Roland) Individual Investor 1.639 2904146 -5440854 2022-10-04 LOW
Franklin Equity Group Investment Advisor 1.4392 2550000 0 2023-02-28 LOW
DWS Investment GmbH Investment Advisor/Hedge Fund 1.2419 2200506 7813 2023-02-28 LOW
California State Teachers Retirement System Pension Fund 1.0986 1946619 1704482 2022-06-30 LOW
Polar Capital LLP Investment Advisor/Hedge Fund 1.0123 1793563 0 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.9995 1770896 17426 2023-02-28 LOW
Baillie Gifford & Co. Investment Advisor 0.8472 1501060 -9797 2023-01-31 LOW
Lanthaler (Werner) Individual Investor 0.8196 1452188 340452 2021-09-30 LOW
Evotec SE Management Corporation 0.7974 1412866 -233297 2021-12-31 LOW

Hvorfor vælge Capital.com? Vores tal taler for sig selv.

Capital.com Group

500K+

Handlende

92K+

Månedlkige, aktive klienter

$53M+

Månedlig investeringsvolumen

$30M+

Hævet hver måned

Handelslommeregner

Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).

Handelskurtage
0
  • 1:1
Gearing
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investering
Handelsstørrelse (Gearing x Investering):
Åben

Luk

Short Long
Tidligere resultater er ikke en pålidelig indikator for fremtidige resultater
Fortjeneste/Tab

Evotec Company profile

Om Evotec AG

Evotec SE er en tysk virksomhed, der beskæftiger sig med forskning i og udvikling af lægemidler. Virksomheden beskæftiger sig med udvikling af nye farmaceutiske produkter gennem forskningsalliancer og udviklingspartnerskaber med farmaceutiske og bioteknologiske virksomheder, akademiske institutioner, patientorganisationer og venturekapitalvirksomheder. Løsningerne inden for lægemiddelforskning leveres i form af vederlag for servicearbejde, integrerede alliancer inden for lægemiddelforskning, udviklingspartnerskaber, licensering af lægemiddelkandidater og konsulentordninger. Evotec SE opererer inden for en række områder, herunder neurovidenskab, diabetes og komplikationer til diabetes, smerte og inflammation, onkologi, infektionssygdomme, luftvejssygdomme og fibrose. Virksomhedens pipeline dækker en række terapeutiske områder som f.eks. CNS-søvnløshed, kronisk hoste, immunologi og inflammation, kvindesundhed, endometriose, nefrologi, dermatologiske sygdomme, fibrotiske sygdomme og antivirale sygdomme m.m.

Industry: Biotechnology & Medical Research (NEC)

Essener Bogen 7
HAMBURG
HAMBURG 22419
DE

Resultatopgørelse

  • Annual
  • Quarterly

Folk ser også

Oil - Crude

70.39 Price
+1.210% 1D Chg, %
Long position, gebyr natten over -0.0170%
Short position, gebyr natten over -0.0050%
Gebyr natten over, tid 21:00 (UTC)
Spænd 0.03

US100

12,780.70 Price
+0.310% 1D Chg, %
Long position, gebyr natten over -0.0241%
Short position, gebyr natten over 0.0018%
Gebyr natten over, tid 21:00 (UTC)
Spænd 1.8

BTC/USD

28,455.60 Price
+0.980% 1D Chg, %
Long position, gebyr natten over -0.0616%
Short position, gebyr natten over 0.0137%
Gebyr natten over, tid 21:00 (UTC)
Spænd 60.00

Gold

1,948.90 Price
+0.410% 1D Chg, %
Long position, gebyr natten over -0.0086%
Short position, gebyr natten over 0.0004%
Gebyr natten over, tid 21:00 (UTC)
Spænd 0.30

Leder du stadig efter en mægler, du kan stole på?

Deltag sammen med 500.000+ handlende over hele verden, der valgte at handle hos Capital.com

1. Opret og bekræft din konto 2. Lav en inddbetaling 3. Find din handel